Intralesional Injection of Bone Marrow Aspirate Concentrate for the Treatment of Osteonecrosis of the Knee Secondary to Systemic Lupus Erythematosus: A Case Report

Dimitrios Kouroupis, Amir F. Ahari, Diego Correa, Riam Shammaa

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Case: An 18-year-old female patient with Systemic Lupus Erythematosus (SLE) and corticosteroid-associated extensive bilateral symptomatic knee Osteonecrosis (ON) (Ficat IV), treated with sequential intralesional injections of autologous bone marrow aspirate concentrate (BMAC) under ultrasound guidance. At 3 months, pain was almost absent (VAS) and KOOS/WOMAC showed significant improvement sustained up to 24 months. At 12 months MRI indicated bone maturation, significantly reduced BM edema and subchondral fluid volume, and no collapse/fragmentation signs. Discussion: The clinical and imaging significant improvement observed in this patient suggests that BMAC intralesional injections effectively restored the compromised bone structure. After larger studies, this technique can become an alternative to decompressing surgery for ON cases.

Original languageEnglish (US)
Article number202
JournalFrontiers in Bioengineering and Biotechnology
Volume8
DOIs
StatePublished - Mar 20 2020

Keywords

  • bone marrow aspirate concentrate
  • bone regeneration
  • cellular therapy
  • endothelial progenitor cells
  • mesenchymal stem cells
  • osteonecrosis
  • systemic lupus erythematosus

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Histology
  • Biomedical Engineering

Fingerprint Dive into the research topics of 'Intralesional Injection of Bone Marrow Aspirate Concentrate for the Treatment of Osteonecrosis of the Knee Secondary to Systemic Lupus Erythematosus: A Case Report'. Together they form a unique fingerprint.

Cite this